AbCellera Biologics (ABCL) Non Operating Income: 2019-2024
Historic Non Operating Income for AbCellera Biologics (ABCL) over the last 6 years, with Dec 2024 value amounting to $114.4 million.
- AbCellera Biologics' Non Operating Income rose 174.13% to $17.5 million in Q4 2023 from the same period last year, while for Dec 2023 it was $63.2 million, marking a year-over-year increase of 179.70%. This contributed to the annual value of $114.4 million for FY2024, which is 81.03% up from last year.
- AbCellera Biologics' Non Operating Income amounted to $114.4 million in FY2024, which was up 81.03% from $63.2 million recorded in FY2023.
- In the past 5 years, AbCellera Biologics' Non Operating Income registered a high of $114.4 million during FY2024, and its lowest value of -$6.8 million during FY2020.
- For the 3-year period, AbCellera Biologics' Non Operating Income averaged around $66.7 million, with its median value being $63.2 million (2023).
- In the last 5 years, AbCellera Biologics' Non Operating Income crashed by 457.35% in 2020 and then skyrocketed by 316.36% in 2021.
- Over the past 5 years, AbCellera Biologics' Non Operating Income (Yearly) stood at -$6.8 million in 2020, then spiked by 316.36% to $14.7 million in 2021, then surged by 53.28% to $22.6 million in 2022, then surged by 179.70% to $63.2 million in 2023, then spiked by 81.03% to $114.4 million in 2024.